Dynavax Technologies (DVAX) 10-Q2005 Q1 Quarterly report

Filed: 9 May 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: absolute, accrued, acquired, Acquiring, added, agency, Alliance, allocated, analyze, antibody, appealed, arrangement, assigned, assurance, assured, asthmatic, attributed, back, binomial, BioSeek, Bulletin, cautioned, cedar, characterize, clear, collectibility, confirmed, consecutive, contingent, criteria, CRO, customer, Deborah, decision, delivered, delivery, detected, dismissed, divided, dividend, dividing, durable, effort, EITF, Emerging, endpoint, escalating, evidence, exceeded, excluded, excluding, explore, fairly, FAS, fixed, flow, fourth, fraud, functioning, headcount, healthcare, healthy, HIV, IIa, immunotherapeutic, incentive, inclusion, incremental, indemnification, indemnified, induced, induction, injectable, interaction, introduce, Japan, KK, life, lifetime, long, lose, maximum, mentioned, met, mild, multiple, nasal, nominal, older, optimize, owed, paid, pediatric, persuasive, pharmacological, pivotal, point, population, postponed, preliminary, prepaid, projected, published, quickly, reevaluating, regained, regimen, registered, reincorporated, relationship, reliable, reliance, rent, reprogrammed, request, resale, revised, robust, rose, route, Ryden, SAB, satisfaction, satisfy, secondary, segment, separate, separately, seroprotection, service, settle, showed, Silicon, Smeltzer, speak, specific, specifically, stand, statistically, summary, superiority, surrendered, survive, table, Task, tenant, terminology, territory, thiazolopyrimidine, title, travel, tree, trend, twelve, typically, TZP, undelivered, underserved, undue, unlimited, Valley, variance, versatile, younger

Removed: advanced, antigen, antiviral, applying, approximating, Asian, begin, block, calculation, called, collateral, computed, confirmatory, consisted, covering, Dawson, default, dilution, disclaim, divest, earn, entirety, evaluating, extend, flexibility, focused, harbor, heightened, identify, intended, investor, irrevocable, issuing, launch, making, maturity, medication, narrative, narrower, negotiated, nonrefundable, pilot, presence, previously, professional, publicly, qualify, receivable, receiving, refer, repayment, restrictive, royalty, scrutiny, standby, steroid, subsequent, substantive, surface, thereto, traded, ultimate, vesting, weighted, William

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

DVAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63
of Title 18 of the United States Code

I, Dino Dina, M.D., hereby certify, pursuant to 18 U.S.C § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the “Company”), that, to the best of my knowledge:

	(i)	The Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

	(ii)	The information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of the Company.



Date: May 9, 2005	By:	/s/ DINO DINA, M.D.
		Dino Dina, M.D.
		President, Chief Executive Officer and Director (Principal Executive Officer)